Conduit Pharmaceuticals Inc (CDT)

$2.36 -0.05 (-2.07%)
Market Cap 1.92M
Revenue (ttm) 0.00
Net Income (ttm) -17.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 125,500
Avg Vol 404,752
Day's Range N/A - N/A
Shares Out 798,000.00
Stochastic %K 15%
Beta 1.97
Analysts Strong Buy
Price Target N/A

Company Profile

Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility...

Industry: Biotechnology
Sector: Healthcare
Phone: (646)-491-9132
Address:
4581 Tamiami Trail North, Suite 200, Naples, United States
ninanoo
ninanoo Jul. 12 at 5:06 PM
$CDT You can verify the correct information by referring to the DEF 14A report. “The beneficial ownership of our Common Stock is based on 2,405,140 shares of Common Stock issued and outstanding as of July 3, 2025, which number excludes the shares of Common Stock issuable upon exercise of the warrants.”
1 · Reply
MrShubby
MrShubby Jul. 12 at 12:27 AM
$CDT outstanding shares is 2,405,140 now
1 · Reply
DORO879
DORO879 Jul. 11 at 11:30 PM
$CDT 5 680 000 $ market cap monday ? Or bug ? So if it's true 5 680 000 ÷ 755 900 = 7,51 $ Maybe 7,51 $ Per shares monday july 14, 2025 ?
1 · Reply
Adarali
Adarali Jul. 11 at 9:58 PM
$CDT here is dip.. Only buy and wait.. We will see 8$
2 · Reply
chonkybottomfeeder
chonkybottomfeeder Jul. 11 at 9:51 PM
$CDT i.dont think they will r/s anytime soon....💀
1 · Reply
MrShubby
MrShubby Jul. 11 at 6:47 PM
$CDT holding, next week will be for longs
4 · Reply
Bluesclues692
Bluesclues692 Jul. 11 at 2:47 PM
$CDT yeah... i dont think im ever holding a position over night after this... Fucking ass hat of a stock ngl lmao
2 · Reply
Bittiesandteer
Bittiesandteer Jul. 11 at 11:26 AM
$CDT almost half held by insiders
1 · Reply
uddin
uddin Jul. 11 at 10:57 AM
$MLGO $CDT Future stock 💯🔥
0 · Reply
TATTED_KEN
TATTED_KEN Jul. 11 at 8:37 AM
$LGHL if you’re not using IBKR or Webull for your trading, you’re leaving a lot of money on the table. Most of this ticker love to run from 4-6am. $DXF it will run eventually 🎯 $14. Adding $CDT held $2.2 like a champ. Let’s have a killing Friday bulls 👊🏼
1 · Reply
Latest News on CDT
Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 8, 2025, 8:30 AM EDT - 4 days ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jul 7, 2025, 8:30 AM EDT - 5 days ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Jun 4, 2025, 8:30 AM EDT - 5 weeks ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 22, 2025, 8:30 AM EDT - 7 weeks ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 21, 2025, 8:30 AM EDT - 7 weeks ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 16, 2025, 8:30 AM EDT - 2 months ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 9, 2025, 8:30 AM EDT - 2 months ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

May 8, 2025, 8:30 AM EDT - 2 months ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Conduit Pharmaceuticals Announces Leadership Changes

Apr 16, 2025, 8:30 AM EDT - 3 months ago

Conduit Pharmaceuticals Announces Leadership Changes

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Apr 11, 2025, 8:30 AM EDT - 3 months ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 31, 2025, 8:30 AM EDT - 3 months ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 19, 2025, 8:30 AM EDT - 4 months ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Mar 6, 2025, 9:35 AM EST - 4 months ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 20, 2025, 8:00 AM EST - 5 months ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 13, 2025, 8:00 AM EST - 5 months ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 11, 2025, 9:00 AM EST - 5 months ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Feb 7, 2025, 8:00 AM EST - 5 months ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Jan 28, 2025, 5:30 AM EST - 5 months ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Dec 12, 2024, 7:30 AM EST - 7 months ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 21, 2024, 7:30 AM EST - 8 months ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 19, 2024, 4:30 PM EST - 8 months ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 4, 2024, 7:30 AM EST - 8 months ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Nov 1, 2024, 4:45 PM EDT - 9 months ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 12, 2024, 7:00 AM EDT - 11 months ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

Aug 8, 2024, 6:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

AstraZeneca furthers ambition to transform outcomes in early lung cancer and ​redefine metastatic breast cancer treatment at ASCO 2024​

May 22, 2024, 7:00 AM EDT - 1 year ago

AstraZeneca furthers ambition to transform outcomes in early lung cancer and ​redefine metastatic breast cancer treatment at ASCO 2024​

AZN

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

May 21, 2024, 8:00 AM EDT - 1 year ago

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Mar 19, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Mar 11, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Jan 31, 2024, 8:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Nov 2, 2023, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 1 year ago

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

Sep 22, 2023, 9:01 AM EDT - 1 year ago

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

ninanoo
ninanoo Jul. 12 at 5:06 PM
$CDT You can verify the correct information by referring to the DEF 14A report. “The beneficial ownership of our Common Stock is based on 2,405,140 shares of Common Stock issued and outstanding as of July 3, 2025, which number excludes the shares of Common Stock issuable upon exercise of the warrants.”
1 · Reply
MrShubby
MrShubby Jul. 12 at 12:27 AM
$CDT outstanding shares is 2,405,140 now
1 · Reply
DORO879
DORO879 Jul. 11 at 11:30 PM
$CDT 5 680 000 $ market cap monday ? Or bug ? So if it's true 5 680 000 ÷ 755 900 = 7,51 $ Maybe 7,51 $ Per shares monday july 14, 2025 ?
1 · Reply
Adarali
Adarali Jul. 11 at 9:58 PM
$CDT here is dip.. Only buy and wait.. We will see 8$
2 · Reply
chonkybottomfeeder
chonkybottomfeeder Jul. 11 at 9:51 PM
$CDT i.dont think they will r/s anytime soon....💀
1 · Reply
MrShubby
MrShubby Jul. 11 at 6:47 PM
$CDT holding, next week will be for longs
4 · Reply
Bluesclues692
Bluesclues692 Jul. 11 at 2:47 PM
$CDT yeah... i dont think im ever holding a position over night after this... Fucking ass hat of a stock ngl lmao
2 · Reply
Bittiesandteer
Bittiesandteer Jul. 11 at 11:26 AM
$CDT almost half held by insiders
1 · Reply
uddin
uddin Jul. 11 at 10:57 AM
$MLGO $CDT Future stock 💯🔥
0 · Reply
TATTED_KEN
TATTED_KEN Jul. 11 at 8:37 AM
$LGHL if you’re not using IBKR or Webull for your trading, you’re leaving a lot of money on the table. Most of this ticker love to run from 4-6am. $DXF it will run eventually 🎯 $14. Adding $CDT held $2.2 like a champ. Let’s have a killing Friday bulls 👊🏼
1 · Reply
Adarali
Adarali Jul. 10 at 11:22 PM
$CDT bomm..
0 · Reply
Nevilhch
Nevilhch Jul. 10 at 10:54 PM
$CDT
0 · Reply
WaarrenBuffett
WaarrenBuffett Jul. 10 at 10:25 PM
$BTC.X 🔥🫶🤗 Smoother Gem MICRO float Crypto strategy Reserve!!! $CDT
0 · Reply
fisher04
fisher04 Jul. 10 at 8:17 PM
$CDT reversal tomorrow.. and news next week . hold and add shares to average down .
1 · Reply
fisher04
fisher04 Jul. 10 at 8:16 PM
$CDT this vote was only about choosing people for different roles . why you shitting on yourself..
1 · Reply
Valcon_s
Valcon_s Jul. 10 at 7:09 PM
$CDT Just voted. Bet you the only reason this stock is up 1% right now is because we gotta Vote for shit. I voted to f up their plans. Bastard stock wants me to help the company after getting it robbed & abused me. No.
0 · Reply
fiddledjinn
fiddledjinn Jul. 10 at 6:06 PM
$CDT l like the action today
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 10 at 6:04 PM
$CDT $APLM will need u 2 as well
0 · Reply
Bubbasoup09
Bubbasoup09 Jul. 10 at 5:01 PM
$CDT reloaded
0 · Reply
MrShubby
MrShubby Jul. 10 at 3:50 PM
$CDT @iambaron still believe?
3 · Reply
fisher04
fisher04 Jul. 10 at 3:24 PM
$CDT added more .
0 · Reply
Valcon_s
Valcon_s Jul. 10 at 3:12 PM
$CDT Always. If history repeats itself, this will eventually go to 1,75$ at the end of the next 3 months and then run to 3,6$. Afterwich it wiuld plummet. Unless there is actually more "good news" ahead, or more dilution. Would never hold this shit if I had any real money. I hope it goes bankrupt and the scammers running it thrown in jail.
0 · Reply